Dimensional Fund Advisors
HRMY icon

Dimensional Fund Advisors’s Harmony Biosciences HRMY Stock Holding History

Dimensional Fund Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.1M Buy
2,393,588
+317,078
+15% +$10M 0.02% 1281
2026
Q1 		$58.2M Buy
2,076,510
+245,784
+13% +$8.06M 0.01% 1420
2025
Q4 		$68.5M Buy
1,830,726
+139,145
+8% +$4.58M 0.01% 1333
2025
Q3 		$46.6M Buy
1,691,581
+109,405
+7% +$3.77M 0.01% 1559
2025
Q2 		$50M Buy
1,582,176
+357,382
+29% +$11.5M 0.01% 1497
2025
Q1 		$40.7M Buy
1,224,794
+11,765
+1% +$422K 0.01% 1581
2024
Q4 		$41.7M Buy
1,213,029
+160,490
+15% +$5.51M 0.01% 1616
2024
Q3 		$42.1M Buy
1,052,539
+95,754
+10% +$3.36M 0.01% 1607
2024
Q2 		$28.9M Buy
956,785
+112,197
+13% +$3.37M 0.01% 1774
2024
Q1 		$28.4M Buy
844,588
+108,320
+15% +$3.48M 0.01% 1810
2023
Q4 		$23.8M Sell
736,268
-48,176
-6% -$1.34M 0.01% 1896
2023
Q3 		$25.7M Buy
784,444
+51,893
+7% +$1.8M 0.01% 1785
2023
Q2 		$25.8M Sell
732,551
-99,476
-12% -$3.43M 0.01% 1796
2023
Q1 		$27.2M Buy
+832,027
New +$37.9M 0.01% 1751
2022
Q3 		$24.9M Buy
562,770
+105,082
+23% +$5.13M 0.01% 1698
2022
Q2 		$22.3M Buy
457,688
+111,636
+32% +$5.03M 0.01% 1797
2022
Q1 		$16.8M Buy
346,052
+150,931
+77% +$6.16M 0.01% 2054
2021
Q4 		$8.32M Buy
195,121
+158,725
+436% +$6.33M ﹤0.01% 2376
2021
Q3 		$1.4M Buy
+36,396
New +$1.17M ﹤0.01% 2955

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Dimensional Fund Advisors's HRMY Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Harmony Biosciences (HRMY) stake by 15% in Q2 2026, buying an estimated $10M and bringing the position to 2,393,588 shares worth $87.1M. The position accounts for 0.02% of the portfolio, ranked #1281.

Dimensional Fund Advisors first reported a position in HRMY in Q3 2021 and has held it in 19 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Dimensional Fund Advisors held 2,393,588 shares of Harmony Biosciences worth $87.1M as of Q2 2026.
  • Dimensional Fund Advisors bought 317,078 Harmony Biosciences shares in Q2 2026, an estimated $10M.
  • Harmony Biosciences made up 0.02% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1281 holding.
  • Dimensional Fund Advisors first reported a position in Harmony Biosciences in Q3 2021 and has held it in 19 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.